A new agreement between Memorial Hermann and Blue Cross Blue Shield ends weeks of uncertainty for insured patients in Houston ...
The addition of Foundayo expands LifeMD’s offerings of branded GLP-1 therapies from both Lilly and Novo Nordisk and reinforces LifeMD’s position as a leading destination for clinically guided weight ...
D&O Coverage Analysis Now Automated. While the Insurance Industry Invested Billions in AI for Underwriting and Fraud, Financial Lines Claims -- The Most Legally Complex Segment -- Was Left Entirely ...
MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...
A Rivian owner spent a week with the $100,000 Hummer EV and found it "annoyingly huge." With bad sightlines and a cabin that ...
James River Insurance Co. ended its suit against a cannabis testing company over coverage for claims related to the lab’s suspended license. The US District Court for the Southern District of ...
We have written before about what specific blood panels reveal and how vitamin deficiencies show up in your bloodwork. Those articles focused on what the numbers mean once you have them. But there is ...
GitHub is adopting AI-based scanning for its Code Security tool to expand vulnerability detections beyond the CodeQL static analysis and cover more languages and frameworks. The developer ...
The Wu administration will soon limit coverage of GLP-1 weight loss drugs and other medications for city employees and retirees, a move officials say will save Boston nearly $11 million amid an ...
BOSTON – A Florida-based doctor has pleaded guilty in federal court in Boston to making false statements in connection with a multi-million-dollar health care fraud scheme involving medically ...
The BBC is once again defending itself over its decision not to broadcast the 2026 Commonwealth Day Service on its main channel, despite agreeing to air the Installation of the Archbishop of ...
Congressman John Garamendi, a senior member of the House Armed Services Committee and Co-Chair of the Congressional Nuclear Weapons and Arms Control Working Group, issued the following statement in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果